[Use of recombinant hematopoietic growth factors after chemotherapy and high-dose chemo-radiotherapy].
Gianni
A M
AM
Bregni
M
M
Siena
S
S
Tarella
C
C
D000741:Anemia, Aplastic / Q000188:drug therapy* / Q000209:etiology; D000970:Antineoplastic Agents / Q000009:adverse effects*; D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D003131:Combined Modality Therapy / Q000009:adverse effects; D003520:Cyclophosphamide / Q000009:adverse effects; D003561:Cytarabine / Q000009:adverse effects; D004341:Drug Evaluation; D005047:Etoposide / Q000009:adverse effects; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007938:Leukemia / Q000150:complications / Q000628:therapy; D008558:Melphalan / Q000009:adverse effects; D009369:Neoplasms / Q000150:complications / Q000628:therapy; D011878:Radiotherapy / Q000009:adverse effects*
D000970:Antineoplastic Agents; D003115:Colony-Stimulating Factors; D003561:Cytarabine; D005047:Etoposide; D003520:Cyclophosphamide; D008558:Melphalan
Impiego di fattori di crescita emopoietici ricombinanti dopo chemioterapia e chemioradioterapia ad alte dosi.